Covid-19: India's Serum Institute applies for full approval of Covishield vaccine

Serum Institute produces AstraZeneca's Covid-19 vaccine under the brand name Covishield.



Agencies file
Agencies file

By Reuters

Published: Fri 31 Dec 2021, 11:18 AM

Serum Institute Of India has applied to the country's drug regulator and the health ministry for full market authorisation of its Covid-19 vaccine, Covishield, the company's chief executive said in a tweet on Friday.

Serum Institute produces AstraZeneca's Covid-19 vaccine under the brand name Covishield.

ALSO READ:


More news from coronavirus